1. Comparison of resectable and unresectable periampullary carcinomas;Shyr;J Am Coll Surg,1994
2. The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer;Lundin;Br J Surg,1994
3. CA 242, a new tumor marker for pancreatic cancer;Haglund;Br J Surg,1994
4. The clinical utility of CA 19-9 tumor-associated antigen;Steinberg;Am J Gastroenterol,1990
5. Enzyme-linked PNA lectin binding assay compared with CA 19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer;Ching;Br J Surg,1989